The Role of Blood-Based Biomarkers in Transforming Alzheimer’s Disease Research and Clinical Management: A Review

View Full Paper

Ask AI

Bookmark

Authors

Discussion

This review highlights blood-based biomarkers enhancing diagnostic accuracy in Alzheimer's disease, suggesting potential for clinical application.

Blood-based biomarkers improve early detection and monitoring of Alzheimer's disease, enhancing clinical management.
Recent advances enable reliable quantification of plasma Aβ isoforms and phosphorylated tau variants, crucial for diagnosis.
Observational analysis provides insights into the biological relevance and diagnostic accuracy of these biomarkers in Alzheimer's disease.
Challenges such as standardization need addressing for broader clinical implementation of blood-based biomarkers.

Maschio et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

This review highlights blood-based biomarkers enhancing diagnostic accuracy in Alzheimer's disease, suggesting potential for clinical application.